Now Reading
Special Session Highlights Strengthening of Infrastructure in Tanzania to Fight HIV/AIDS
Special Session Highlights Strengthening of Infrastructure in Tanzania to Fight HIV/AIDS
Published 05-25-05
Submitted by Abbott
Infrastructure is the subject of this year's Global Health Council (GHC) annual meeting. One unique program in Tanzania is addressing this bottleneck head on and laying the groundwork for PEPFAR treatment programs: Tanzania Care, a public-private partnership of the Abbott Fund and the Tanzania Ministry of Health, is strengthening the country's public health infrastructure at every point, including modernizing the national hospital's outpatient treatment center and laboratories; creating a national system of referral hospitals; improving hospital management, administration and systems; training health care staff; and expanding health capacity and HIV testing nationwide, thereby increasing the entry points for patients into treatment and care.
A special session at the GHC meeting will feature experts directly involved in the program in Tanzania, and will discuss progress, as well as the technical, managerial and political challenges encountered, lessons learned and how the private and public sectors can combine their core competencies to improve health care.
WHO:
WHERE:
Omni Shoreham Hotel - Diplomat Ballroom
2500 Calvert Street NW (at Connecticut Ave.), Washington, D.C.
WHEN:
Wednesday, June 1 - Luncheon session
12:30 p.m. - 2:00 p.m.
Spokespeople will be available at other times from May 31 - June 3
NOTE: To schedule an interview with the panelists or to attend the panel discussion, contact:
Abbott
Abbott
About Abbott and the Abbott Fund
The Abbott Fund is a philanthropic foundation established by Abbott in 1951. The Abbott Fund's mission is to create healthier global communities by investing in creative ideas that promote science, expand access to health care and strengthen communities worldwide. For more information, visit www.abbottfund.org.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's website at www.abbott.com.
More from Abbott
